Compare2 funds · 1 pair
Picked · 2YTD
BIBvsVIGVersus · 5Y · 1.8% held in common1–5measures won
Close to theseFee · YTD
Best of the twoNov 6
  • Lowest cost$ a year on $10kVIG 0.04%
  • Most incometrailing 12-month yieldVIG 1.50%
  • Best 5 yearsper yearVIG +10.2%
  • Smallest drop · 1Yworst fall in the past yearVIG −7.9%
Measures won1–5VIG wins · of 6 · 5Y
$10,000 · 5Y$16,243VIG · BIB $13,309
Lowest cost0.04%VIG · $4 on $10k
Most income1.50%VIG · $150 on $10k
Smallest drop−7.9%VIG · worst fall in 1Y
Held in common1.8%BIB and VIG

BIB vs VIG

5Y
BIB
VIG
ProShares Ultra Nasdaq Biotechnology · $102MVanguard Dividend Appreciation ETF · $109B
+41.4%3 years · per year$28,273 · $16,669+18.6%
+5.9%5 years · per year$13,309 · $16,243+10.2%
1.17%Expense ratio$117 · $4 on $10k · lower wins0.04%
0.19%12-mo yield$19 · $150 on $10k1.50%
−17.9%Worst dropSmaller wins−7.9%
46.2%VolatilityLower wins10.8%
1–5VIG wins
$10,000 · 5 yearsOne scale
$10k startVIG $16.2kBIB $13.3kOct 2021Nov 2026
Shared top holdingsBIB · VIG
5.5%AMGN1.0%
5.9%GILD0.8%
Held in common1.8%
End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

Both

5Y2 funds
#Trend
1BVIGVanguard Dividend Appreciation ETFReadDesk0.04%1.50%−0.4%+12.1%+14.3%+18.6%+10.2%−7.9%$109.1B
2ABIBProShares Ultra Nasdaq BiotechnologyReadDesk1.17%0.19%+4.5%+47.7%+68.1%+41.4%+5.9%−17.9%$102M
End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BIB vs VIG

5Y
ProShares Ultra Nasdaq Biotechnology
$13,309
Vanguard Dividend Appreciation
$16,243
$5k$10k$15kNov 2021Nov 2026$13,309$16,243$5k$10k$15kNov 2021Nov 2026$13,309$16,243
MeasureBIBVIG
Fee1.17%0.04%
Cost on $10k a year$117$4
Yield0.19%1.50%
5 years, per year+5.9%+10.2%
3 years, per year+41.4%+18.6%
Worst drop · 1Y−17.9%−7.9%
Volatility · 1Y46.2%10.8%
5–1measures won
VIG first
1.8%
holdings shared
Nov 6, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+31.4%
VIGVanguard
+12.1%
Jan 1Nov 6+31.4%+12.1%
+31.4%Year to date+12.1%
3.0%Yield1.5%
$120BAssets$109B
2–0SCHD wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

DGRO vs VIG

YTD
iSharesDGRO
+16.6%
VIGVanguard
+12.1%
Jan 1Nov 6+16.6%+12.1%
+16.6%Year to date+12.1%
1.9%Yield1.5%
$44.7BAssets$109B
2–0DGRO wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+3.2%
JEPIJ.P. Morgan
+5.3%
Jan 1Nov 6+3.2%+5.3%
+3.2%Year to date+5.3%
12.8%Yield8.1%
$42.6BAssets$46.8B
1–1level
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

Overlap: BIB, VIG

Today
1.8%most shared, BIB and VIG
BIBVIG
BIB—1.8%
VIG1.8%—
End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$146most kept, VIG
VIG$150 − $4 = $146
BIB$19 − $117 = −$98
KeptFee
End-of-day Nov 6, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com